Skip to main content
SpringerLink
Log in

Letter to the Editor

  • Letter to the Editor
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. Sartor RB: Role of intestinal microfiora in initiation and perpetuation of in flammatory bowel disease. Can J Gastroenterol 4:271-277, 1990

    Google Scholar 

  2. Chadwick VS, Anderson RP: Micro-organisms and their products in in flammatory bowel disease. In In flammatory Bowel Disease. RP MacDe rmott, WF Stenson (eds). New York, Elsevier, 1992, pp 241–258

    Google Scholar 

  3. Burke DA, Axon ATR, Clayden SA, Dixon MF, Johnston D, Lacey RW: The efficacy of tobramycin in the treatment of ulcerative colitis. Aliment Pharmacol Ther 4:123–129, 1990

    Google Scholar 

  4. Mantzaris GJ, Hatzis A, Kontogiannis P, Triadaphyllou G: Intravenous tobramycin and me tronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitis. Am J Gastroenterol 1:43–46, 1994

    Google Scholar 

  5. Descombe JJ, Dubourg D, Picard M, Palazzini E: Pharmacokinetic study of rifaximin after oral administration in healthy volunteers. Int J Clin Pharmacol Res 14:51–56, 1994

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Letter to the Editor. Dig Dis Sci 44, 1220–1221 (1999). https://doi.org/10.1023/A:1026648812439

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026648812439

Keywords

Search

Navigation